The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overexpression of alpha enolase in hepatitis C virus‐related hepatocellular carcinoma: Association with tumor progression as determined by proteomic analysis
Abstract
To identify proteins that could be molecular targets for diagnosis and treatment of hepatitis C virus‐related hepatocellular carcinoma (HCV‐related HCC), we used a proteomic approach to analyze protein expression in samples of human liver. Twenty‐six pairs of tumorous and corresponding nontumorous liver samples from patients with HCV‐related HCC and six normal liver samples were analyzed by two‐dimensional gel electrophoresis and liquid chromatography‐tandem mass spectrometry. One of the numerous spots that showed stronger intensity in tumorous than in nontumorous samples was identified as alpha enolase, a key enzyme in the glycolytic pathway. Expression of this protein increased with tumor dedifferentiation and was significantly higher in poorly differentiated HCC than in well‐differentiated HCC. This pattern was reproduced by immunoblot analysis and immunohistochemistry. Expression of alpha enolase also correlated positively with tumor size and venous invasion. These results suggest that alpha enolase is one of the candidates for biomarkers for tumor progression that deserves further investigation in HCV‐related HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Durany, N., Joseph, J., Jimenez, O. M., Climent, F., Fernández, P. L., Rivera, F., & Carreras, J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0871 · Cited by 76
Cited by
α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations
Díaz-Ramos, À., Roig-Borrellas, A., García-Melero, A., & López-Alemany, R. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/156795 · Cited by 373
Metadata
- Authors
- Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N., Fujimoto, M., Nishisaka, T., Okita, K., Oka, M., & Nakamura, K.
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2005-04
- Volume
- 5
- Issue
- 6
- Pages
- 1686-1692
- ISSN
- 1615-9853 (ISSN-L)
- 1615-9861
- OpenAlex
- W2115287848
- Cited by
- 158
- References
- 1
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.